Behavioural and neurochemical mechanisms underpinning the feeding-suppressive effect of GLP-1/CCK combinatorial therapy.

Molecular Metabolism
Emma RothClemence Blouet

Abstract

Combinatorial therapies are under intense investigation to develop more efficient anti-obesity drugs; however, little is known about how they act in the brain to produce enhanced anorexia and weight loss. The goal of this study was to identify the brain sites and neuronal populations engaged during the co-administration of GLP-1R and CCK1R agonists, an efficient combination therapy in obese rodents. We measured acute and long-term feeding and body weight responses and neuronal activation patterns throughout the neuraxis and in specific neuronal subsets in response to GLP-1R and CCK1R agonists administered alone or in combination in lean and high-fat diet fed mice. We used PhosphoTRAP to obtain unbiased molecular markers for neuronal populations selectively activated by the combination of the two agonists. The initial anorectic response to GLP-1R and CCK1R co-agonism was mediated by a reduction in meal size, but over a few hours, a reduction in meal number accounted for the sustained feeding suppressive effects. The nucleus of the solitary tract (NTS) is one of the few brain sites where GLP-1R and CCK1R signalling interact to produce enhanced neuronal activation. None of the previously categorised NTS neuronal subpopulations rel...Continue Reading

References

Apr 24, 2004·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Jean-Pierre GutzwillerChristoph Beglinger
Mar 15, 2006·International Journal of Obesity : Journal of the International Association for the Study of Obesity·C M MackA A Young
Feb 13, 2007·Regulatory Peptides·Diane M HargroveChristen M Anderson
Jan 30, 2009·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Tanja BabicHans-Rudolf Berthoud
May 27, 2010·Brain Research·Tanja BabicChristopher D Morrison
Oct 1, 2011·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Jon M ReschSujean Choi
Oct 25, 2011·Expert Opinion on Investigational Drugs·Franco Folli, Rodolfo Guardado Mendoza
Nov 28, 2012·Cell·Zachary A KnightJeffrey M Friedman
Jan 23, 2013·International Journal of Obesity : Journal of the International Association for the Study of Obesity·J A ParkerS R Bloom
Mar 13, 2013·Nature Reviews. Endocrinology·Sharon A Sadry, Daniel J Drucker
Feb 4, 2014·Nature·Michael J KrashesBradford B Lowell
Mar 25, 2014·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Yan WangSteven W Taylor
Sep 10, 2014·The Journal of Clinical Investigation·Anna SecherLotte Bjerre Knudsen
Feb 7, 2017·Nature Neuroscience·John N CampbellLinus T Tsai
Apr 29, 2018·Trends in Neurosciences·Richard D Palmiter

❮ Previous
Next ❯

Methods Mentioned

BETA
pharmacotherapies
immunoprecipitation
RNA
chips
Smart Seq
Assay
dissections
RNAseq

Software Mentioned

HALO
PhosphoTRAP
RNAscope
ImageJ

Related Concepts

Related Feeds

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.

Anorexia Nervosa

Anorexia nervosa (AN) is a psychiatric condition characterized by severe weight loss and secondary problems associated with malnutrition. Here is the latest research on AN.